We are live on ! Find out more
MGNX icon

MacroGenics

126 hedge funds and large institutions have $518M invested in MacroGenics in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 52 increasing their positions, 36 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 36

8% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 12

2% less funds holding

Funds holding: 128126 (-2)

39% less capital invested

Capital invested by funds: $856M → $518M (-$337M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $285K

Holders
126
Holders Change
-2
Holders Change %
-1.56%
% of All Funds
3.36%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
11
Increased
52
Reduced
36
Closed
12
Calls
Puts
$285K
Net Calls
-$285K
Net Calls Change
-$1.53M
Name Holding Trade Value Shares
Change
Change in
Stake
SIM
26
Spark Investment Management
New York
$5.54M +$1.68M +88,200 +43%
First Eagle Investment Management
27
First Eagle Investment Management
New York
$5.36M -$80K -4,200 -1%
TA
28
Teachers Advisors
New York
$4.24M +$278K +14,600 +7%
RSCM
29
Rock Springs Capital Management
Maryland
$4.22M +$133K +7,000 +3%
Jennison Associates
30
Jennison Associates
New York
$3.68M -$1.35M -70,973 -27%
JP Morgan Chase
31
JP Morgan Chase
New York
$3.07M -$1.6K -84 -0.1%
SFM
32
Sphera Funds Management
Israel
$2.87M
Bank of New York Mellon
33
Bank of New York Mellon
New York
$2.46M -$83K -4,362 -3%
DCM
34
Driehaus Capital Management
Illinois
$2.27M -$3.74M -196,614 -62%
Balyasny Asset Management
35
Balyasny Asset Management
Illinois
$2.25M -$291K -15,271 -11%
RPAM
36
Rhenman & Partners Asset Management
Sweden
$2.25M +$495K +26,000 +28%
CS
37
Candriam SCA
Luxembourg
$2.2M -$326K -17,100 -13%
Principal Financial Group
38
Principal Financial Group
Iowa
$2.18M
BIM
39
BlackRock Investment Management
Delaware
$2.12M +$34.9K +1,835 +2%
Marshall Wace
40
Marshall Wace
United Kingdom
$1.94M +$186K +9,749 +10%
Charles Schwab
41
Charles Schwab
California
$1.81M -$96.4K -5,065 -5%
TCIM
42
TIAA CREF Investment Management
New York
$1.76M -$226K -11,859 -11%
SCM
43
Suffolk Capital Management
New York
$1.75M +$30.8K +1,617 +2%
Citadel Advisors
44
Citadel Advisors
Florida
$1.74M +$1.6M +84,174 +955%
TC
45
TFS Capital
Pennsylvania
$1.63M -$546K -28,686 -25%
BG
46
Bellevue Group
Switzerland
$1.56M +$1.58M +83,000 New
Jacobs Levy Equity Management
47
Jacobs Levy Equity Management
New Jersey
$1.55M +$1.58M +82,957 New
CCMH
48
Cornerstone Capital Management Holdings
New York
$1.35M +$524K +27,500 +61%
MC
49
Muhlenkamp & Co
Pennsylvania
$1.26M +$15.9K +835 +1%
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$1.25M +$159K +8,353 +14%

MGNX Hedge Fund Activity: Q1 2016 in Review

126 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q1 2016, worth a combined $518M — down 39% from $856M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of MGNX and 11 opened new positions — a net loss of 1 holder — while 36 trimmed existing stakes and 52 added.

The largest buyer was Point72 Asset Management, adding an estimated $4.16M. The largest seller was EverPoint Asset Management, cutting an estimated $4.92M.

  • 126 institutional investors held MacroGenics (MGNX) as of Q1 2016, down from 128 in Q4 2015.
  • Funds reported $518M of MacroGenics stock for Q1 2016, down 39% quarter-over-quarter.
  • 11 funds opened new MacroGenics positions in Q1 2016 and 12 closed out, a net change of -1 holder.
  • The largest MacroGenics buyer in Q1 2016 was Point72 Asset Management, an estimated $4.16M added.
  • The largest MacroGenics seller in Q1 2016 was EverPoint Asset Management, an estimated $4.92M sold.

Based on aggregated 13F filings for Q1 2016.